Omidenepag Matches Latanoprost for Glaucoma Omidenepag Matches Latanoprost for Glaucoma

A phase 3 noninferiority trial shows omidenepag almost as efficacious, but with more side effects than latanoprost in people with glaucoma or intraocular hypertension.Medscape Medical News

Source: Medscape Medical News Headlines - November 15, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news